FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149069933> ?p ?o ?g. }

• W2149069933 endingPage "828" @default.
• W2149069933 startingPage "813" @default.
• W2149069933 abstract "Objectives:To perform a systematic up-to-date review and critical discussion of potential clinical applications of cangrelor based on its pharmacologic properties and the main findings from randomized clinical studies.Methods:A database search (PubMed, CENTRAL and Google Scholar) by two independent investigators, including proceedings from scientific sessions of ACC, AHA, ESC, TCT and EuroPCR, from January 1998 through December 2013.Results:Cangrelor is a potent, intravenous, direct-acting P2Y12 antagonist with rapid onset and quickly reversible action. In contrast to ticagrelor, cangrelor’s interaction with thienopiridines requires termination of cangrelor infusion before switching to clopidogrel or prasugrel. According to randomized trials, a cangrelor–clopidogrel combination is relatively safe and more effective than the standard clopidogrel regimen in both urgent and elective percutaneous coronary intervention (PCI) settings, with the advantage of this drug combination fully evident when the universal definition of myocardial infarction is applied. In contrast to available antiplatelet drugs with delayed onset and offset of action, its favorable properties make cangrelor a desirable agent for ad hoc elective PCI, high risk acute coronary syndromes treated with immediate coronary stenting and for bridging those surgery patients who require periprocedural P2Y12 inhibition. Current evidence on cangrelor therapy is limited by the lack of adequately powered studies assessing cangrelor co-administration either with prasugrel or ticagrelor, suboptimal design of some of the trials favoring cangrelor, potentially attenuated benefits with modern stent design, and finally, by the lack of survival advantage.Conclusions:With its pharmacokinetic and pharmacodynamic advantages, allowing consistent and strong P2Y12 inhibition, and with its rapid onset and swift reversal of action devoid of need for an antidote, cangrelor might improve clinical outcomes in clopidogrel-treated patients by reducing ischemic events, while maintaining a favorable safety profile. However, further studies, addressing the safety and efficacy of cangrelor on top of novel oral P2Y12 inhibitors, are warranted." @default.
• W2149069933 created "2016-06-24" @default.
• W2149069933 creator A5011626347 @default.
• W2149069933 creator A5012918602 @default.
• W2149069933 creator A5018550267 @default.
• W2149069933 creator A5030107346 @default.
• W2149069933 creator A5037954844 @default.
• W2149069933 creator A5052583000 @default.
• W2149069933 creator A5062604500 @default.
• W2149069933 creator A5067379673 @default.
• W2149069933 creator A5067935886 @default.
• W2149069933 creator A5072561222 @default.
• W2149069933 date "2014-01-24" @default.
• W2149069933 modified "2023-10-16" @default.
• W2149069933 title "Cangrelor: an emerging therapeutic option for patients with coronary artery disease" @default.
• W2149069933 cites W1484537339 @default.
• W2149069933 cites W1538301903 @default.
• W2149069933 cites W1538704194 @default.
• W2149069933 cites W1569796594 @default.
• W2149069933 cites W1594729601 @default.
• W2149069933 cites W1939515787 @default.
• W2149069933 cites W1963879877 @default.
• W2149069933 cites W1966180932 @default.
• W2149069933 cites W1966433445 @default.
• W2149069933 cites W1972525652 @default.
• W2149069933 cites W1973911240 @default.
• W2149069933 cites W1978591428 @default.
• W2149069933 cites W1980074266 @default.
• W2149069933 cites W1982658190 @default.
• W2149069933 cites W1986455514 @default.
• W2149069933 cites W1986775812 @default.
• W2149069933 cites W1988121084 @default.
• W2149069933 cites W1989000968 @default.
• W2149069933 cites W1991096813 @default.
• W2149069933 cites W1995966488 @default.
• W2149069933 cites W1996459703 @default.
• W2149069933 cites W2002311059 @default.
• W2149069933 cites W2005501262 @default.
• W2149069933 cites W2006378324 @default.
• W2149069933 cites W2006624707 @default.
• W2149069933 cites W2015170280 @default.
• W2149069933 cites W2018234502 @default.
• W2149069933 cites W2019661749 @default.
• W2149069933 cites W2022537971 @default.
• W2149069933 cites W2030753117 @default.
• W2149069933 cites W2031081426 @default.
• W2149069933 cites W2032441198 @default.
• W2149069933 cites W2037231610 @default.
• W2149069933 cites W2039400286 @default.
• W2149069933 cites W2046469019 @default.
• W2149069933 cites W2048615527 @default.
• W2149069933 cites W2050027713 @default.
• W2149069933 cites W2050043025 @default.
• W2149069933 cites W2052574269 @default.
• W2149069933 cites W2053745347 @default.
• W2149069933 cites W2056293457 @default.
• W2149069933 cites W2060063218 @default.
• W2149069933 cites W2063489644 @default.
• W2149069933 cites W2065390746 @default.
• W2149069933 cites W2066404887 @default.
• W2149069933 cites W2068295374 @default.
• W2149069933 cites W2071686230 @default.
• W2149069933 cites W2073317979 @default.
• W2149069933 cites W2077429173 @default.
• W2149069933 cites W2081076143 @default.
• W2149069933 cites W2086658843 @default.
• W2149069933 cites W2088096773 @default.
• W2149069933 cites W2090210165 @default.
• W2149069933 cites W2093750048 @default.
• W2149069933 cites W2096488065 @default.
• W2149069933 cites W2104969665 @default.
• W2149069933 cites W2111440117 @default.
• W2149069933 cites W2111688638 @default.
• W2149069933 cites W2119541630 @default.
• W2149069933 cites W2119951798 @default.
• W2149069933 cites W2123112974 @default.
• W2149069933 cites W2125093797 @default.
• W2149069933 cites W2128314375 @default.
• W2149069933 cites W2129001881 @default.
• W2149069933 cites W2131189712 @default.
• W2149069933 cites W2133396186 @default.
• W2149069933 cites W2136228924 @default.
• W2149069933 cites W2138739392 @default.
• W2149069933 cites W2140501627 @default.
• W2149069933 cites W2142851865 @default.
• W2149069933 cites W2145062078 @default.
• W2149069933 cites W2145931394 @default.
• W2149069933 cites W2150086052 @default.
• W2149069933 cites W2150655309 @default.
• W2149069933 cites W2153447053 @default.
• W2149069933 cites W2156255513 @default.
• W2149069933 cites W2160205454 @default.
• W2149069933 cites W2163170969 @default.
• W2149069933 cites W2165248515 @default.
• W2149069933 cites W2166950143 @default.
• W2149069933 cites W2169387542 @default.
• W2149069933 cites W2170029016 @default.
• W2149069933 cites W2170311461 @default.

• next